¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"LE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
LE Lupus Erythematosus; È«¹Ý¼º ·çǪ½º(³¶Ã¢)
LE lactate extraction; left ear; left eye; leukocyte elastase; leukoerythrogenic; live embryo; Long Evans [rat]; low exposure; lower extremity; lupus erythematosus [cell]
LEA lower extremity amputation
LEC leukoencephalitis; lower esophageal contractility
LECP low-energy charged particle
LED light-emitting diode; lowest emitting dose; lupus erythematosus disseminatus
LEED low-energy electron diffraction
LEEDS low-energy electron diffraction spectroscopy
LEEP left end-expiratory pressure; loop electrosurgical excision procedure
LEF leukokinesis-enhancing factor; lupus erythematosus factor; lymphoid-enhanced binding factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
LE Leu(5)]-enkephalin
LE Leucine enkephalin
LE Lewis
LE Life expectancy
LE Local excision
LE Long Evan
LE Long-Evans rat
LE Loteprednol etabonate
Le Low energy
LE Lower extremity
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • JrId: 1548
    JournalTitle: Letters in applied microbiology.
    MedAbbr: Lett Appl Microbiol
    ISSN: 0266-8254
    ESSN:
    IsoAbbr: Lett. Appl. Microbiol.
    NlmId: 8510094
  • JrId: 1878
    JournalTitle: Lens and eye toxicity research.
    MedAbbr: Lens Eye Toxic Res
    ISSN: 1042-6922
    ESSN:
    IsoAbbr:
    NlmId: 8916639
  • JrId: 1924
    JournalTitle: Les Bronches.
    MedAbbr: Bronches
    ISSN: 0007-2222
    ESSN:
    IsoAbbr:
    NlmId: 7700862
  • JrId: 2224
    JournalTitle: Leadership in health services = Leadership dans les services de sante.
    MedAbbr: Leadersh Health Serv
    ISSN: 1188-3669
    ESSN:
    IsoAbbr:
    NlmId: 9211318
  • JrId: 2306
    JournalTitle: Leukemia & lymphoma.
    MedAbbr: Leuk Lymphoma
    ISSN: 1042-8194
    ESSN:
    IsoAbbr: Leuk. Lymphoma
    NlmId: 9007422
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • T56.0
    Lead and its compounds
    ³³ ¹× ±× È­ÇÕ¹°
  • M10.1
    Lead-induced gout
    ³³À¯¹ß¼º Åëdz
  • I44.4
    Left anterior fascicular block
    ÁÂÀü ¼¶À¯¼Ó Â÷´Ü
  • I44.7
    Left bundle-branch block, unspecified
    »ó¼¼ºÒ¸íÀÇ Á°¢ Â÷´Ü
  • I44.5
    Left posterior fascicular block
    ÁÂÈÄ ¼¶À¯¼Ó Â÷´Ü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® lead poisoning, saturinism ÇÑ±Û ³³Áßµ¶
¼³¸í   
  ¿ëÇØ¼º ³³À» ÈíÀÔÇϰųª »ïÅ´À¸·Î½á À¯¹ßµÇ´Â Á÷¾÷º´. ±Þ¼º°ú ¸¸¼ºÀÌ ÀÖÀ¸¸ç ´ë·®À¸·Î Èí¼öÇÏ¿© ±Þ¼º À§Àå¿° Áõ»óÀ» ³ªÅ¸³»´Â ±Þ¼º Áßµ¶Àº ¿ÀÈ÷·Á µå¹°°í, ±Ø¼Ò·®(1ÀÏ 1mg ÀÌÇÏ)ÀÇ ³³À» Àå±â°£ Áö¼ÓÀûÀ¸·Î ¼·ÃëÇÔÀ¸·Î½á »ý±â´Â ¸¸¼ºÀÌ ´õ ½É°¢ÇÏ´Ù. ³³Á¦·Ã¾÷-ȰÆÇÀμâ¾÷-µµÀå¾÷-³³À¯¸®Á¦Á¶¾÷-ÃàÀüÁöÁ¦Á¶¾÷ µî ³³ ¶Ç´Â ³³À» ÇÔÀ¯ÇÑ ¹°ÁúÀ» ´Ù·ç´Â »ç¶÷, ¶Ç °ú°Å¿¡´Â ¿¬¹éÀ» »ç¿ëÇÑ ºÐ¿¡ ÀÇÇÑ È­Àåµ¶ÀÌ ¿©¼º¿¡°Ô ³ªÅ¸³ª ¹®Á¦°¡ µÇ¾úÀ¸³ª, ¿À´Ã³¯¿¡´Â °¡¼Ö¸°¿¡ È¥ÇյȠ¾ÈƼ³ìÁ¦ÀΠ»ç¿¡Æ¿³³À¸·Î ÀÎÇÑ Áßµ¶ÀÌ ÁÖ¸ñµÇ°í ÀÖ´Ù. »ç¿¡Æ¿³³ Áßµ¶ÀÇ Áõ»óÀº ¿©·¯ °¡ÁöÀε¥, ºóÇ÷À̳ª ¶³¸®´Â Áõ»óÀÌ ºñ±³Àû Ãʱ⿡ ³ªÅ¸³ª°í ³³¼±(ÀÕ¸ö¿¡ ³³ÀÌ Ä§ÂøÇÏ¿© Ã»È¸¹é»öÀ¸·Î Âø»öµÈ´Ù)À̳ª ¹ßÀÛÀû º¹ÅëÀ̠Ư¡ÀÌ´Ù. ÀϹÝÀûÀ¸·Î ³³ÀÇ Áõ±â³ª °¡·ç°¡ ±âµµ¸¦ ÅëÇØ Ã¼³»·Î µé¾î°¡´Â °æ¿ì°¡ µµ·á-¾È·á¿¡ µé¾î Àִ ³³ÀÌ ÇǺγª ¼ÒÈ­°üÀ» ÅëÇØ Ä§ÅõÇϴ Áõ·Êº¸´Ù Áõ»óÀÌ ½ÉÇÏ´Ù.
¿µ¹® learning ÇÑ±Û ÇнÀ
¼³¸í   
  ¿¬½À ¹× °æÇèÀÇ °á°ú·Î, Çൿ¿¡ ³ªÅ¸³ª´Â ¹Ý¿µ±¸ÀûÀΠº¯È­¸¦ °¡¸®Å°´Â ÀϹÝÀû ¿ë¾î. ÇൿÀÇ º¯È­´Â °üÂûÇÒ ¼ö Àִ Çö»óÀ¸·Î¼­ Æ¯È÷ À̸¦ ¼öÇà(performance)À̶ó°í ºÎ¸£´Â °æ¿ì°¡ Àִµ¥, ±×·¯ÇÑ °æ¿ì¿¡ ±× Çö»óÀÇ ¹èÈÄ¿¡ °¡¼³ÀûÀ¸·Î ±¸¼ºµÈ ½Àµæ(acquisition)ÀÇ °úÁ¤À» ÁöĪÇϰԠµÈ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
¿µ¹® leiomyoma ÇÑ±Û ÆòȰ±ÙÁ¾
¼³¸í   
  ÆòȰ±ÙÀÇ ÀÌ»óºñ´ë·Î ÀÎÇØ »ý±ä ¾ç¼ºÁ¾¾ç. ÁַΠÆòȰ±ÙÀÌ Á¸ÀçÇϴ °÷¿¡ »ý±â´Âµ¥, ÀÚ±Ã, À§Ã¢ÀÚ°ü, ÇǺΠµî¿¡ È£¹ßÇÑ´Ù. Àڱÿ¡ »ý±æ °æ¿ì, »ý¸®ÀÌ»ó, ºÒÀÓ, À¯»ê µîÀ» µ¿¹ÝÇÒ ¼ö ÀÖÀ¸¸ç, ÀÛÀºÃ¢ÀÚºÎÀ§¿¡ »ý±æ °æ¿ì, ¼ÒÈ­Àå¾Ö, ÃâÇ÷ µîÀ» À¯¹ßÇϱ⵵ Çϸç, ¶§·Î´Â ¾Ç¼ºÁ¾¾çÀ¸·Î º¯ÇÒ ¼öµµ ÀÖ´Ù.
¿µ¹® leishmaniasis ÇÑ±Û ¸®½´¸¸Æí¸ðÃæÁõ
¼³¸í   
  ¸®½´¸¶´Ï¾Æ¿¡ ÀÇÇÏ¿© ¹ßº´µÇ´Â °¨¿°ÁõÀ¸·Î, ÆÄ¸®°¡ »ç¶÷ È¤Àº µ¿¹°À» ¹°¾î °¨¿°µÇ¸ç, ³»Àå, ÇǺΠȤÀº Á¡¸· ÇǺκ´À» ÀÏÀ¸Å²´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Le Fort fracture
    ¸£Æ÷¸£°ñÀý
  • Le Fort osteotomy
    ¸£Æ÷»ÀÀÚ¸§(¼ú), ¸£Æ÷Àý°ñ(¼ú)
  • lead
    1. ³³ 2. µµÃâ, À¯µµ 3. Àü±Ø
  • lead acetate
    Ãʻ곳
  • lead colic
    ³³±ÞÅëÁõ
  • lead encephalopathy
    ³³Áßµ¶³úº´(Áõ)
  • lead gout
    ³³Åëdz
  • lead line
    ³³¼±
  • lead neuritis
    ³³Áßµ¶½Å°æº´Áõ
  • lead neuropathy
    ³³Áßµ¶½Å°æº´(Áõ)
  • lead nitrate
    Áú»ê³³
  • lead pipe fracture
    ³³°ü°ñÀý, ³³ÆÄÀÌÇÁ°ñÀý
  • lead pipe phenomenon
    ³³°üÇö»ó
  • lead poisoning
    ³³Áßµ¶
  • lead shield
    ³³º¸È£±¸, ³³Â÷Æó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lead
    1. ³³, 2. µµÃâ, À¯µµ
  • lead poisoning
    ³³Áßµ¶
  • lean body mass
    Áö¹æ»«Ã¼Áß, ¸¶¸¥Ã¼Áß
  • learning
    ÇнÀ
  • learning curve
    ÇнÀ°î¼±
  • learning disorder
    ÇнÀÀå¾Ö
  • leech
    °Å¸Ó¸®
  • left atrial filling pressure
    Á½ɹæ Ãæ¸¸¾Ð
  • left bundle branch block
    Á¹æ½Ç´Ù¹ß°¥·¡Â÷´Ü
  • left lateral segment
    ¿ÞÂʰ¡Âʱ¸¿ª, Á¿ܺÐÀý
  • left ventricle
    ¿Þ½É½Ç, Á½ɽÇ
  • leg
    1.Á¾¾Æ¸®, 2.´Ù¸®
  • leg elevation
    ´Ù¸®³ôÀ̱â
  • Legg-Calve-Perthes disease
    (¢¡ostetochondrosis of the capitualar epiphysis of th) ·¹±×Ä®º£Æä¸£Å×½ºº´, ³Ò´Ù¸®»À¸Ó¸®»À³¡»À¿¬°ñÁõ
  • leiomyoma
    ÆòȰ±ÙÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Le Fort fracture
    ¸£Æ÷°ñÀý
  • Le Fort osteotomy
    ¸£Æ÷»ÀÀÚ¸§¼ú, ¸£Æ÷Àý°ñ¼ú
  • lead
    ³³, µµÃâ, À¯µµ
  • lead acetate
    Ãʻ곳
  • lead colic
    ³³±ÞÅëÁõ
  • lead gout
    ³³Åëdz
  • lead line
    ³³¼±
  • lead neuritis
    (¢¡lead neuropathy) ³³Áßµ¶½Å°æº´Áõ
  • lead neuropathy
    ³³Áßµ¶½Å°æº´Áõ
  • lead nitrate
    Áú»ê³³
  • lead pencil stool
    ¿¬Çʺ¯
  • lead pipe fracture
    ³³ÆÄÀÌÇÁ°ñÀý, ¿¬°ü»ó°ñÀý
  • lead pipe phenomenon
    ³³°üÇö»ó
  • lead poisoning
    ³³Áßµ¶
  • lead shield
    ³³º¸È£±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • LE cell
    LE¼¼Æ÷.
  • LE cell phenomenon
    LE¼¼Æ÷Çö»ó.
  • Le Fort fracture
    »ó¾Ç°ñÀý, ¸£Æ÷Æ®°ñÀý
  • Leads
    µµÃâ(Óôõó), À¯µµ(ë¯Óô)
  • Learning
    ÇнÀ(ùÊã§)
  • Lebensohn chart
    ·¹À̺콼½Ã·ÂÇ¥
  • Lebers congenital amaurosis
    ·¹º£¸£¼±ÃµÈæ¾Ï½Ã
  • Lebers disease
    ·¹º£¸£º´
  • Lecithin
    ·¹½Ãƾ
  • Lecithin-cholesterol acyl transferase
    ·¹½Ãƾ-ÄÝ·¹½ºÅ×·Ñ¾Æ½Ç Æ®·»½ºÆÛ·¹ÀÌÁî
  • Left bundle branch block
    ÁÂÃø°¢Â÷´Ü(ñ§ö°ÊÇó´Ó¨)
  • Left coronary artery
    ¿Þ½ÉÀ嵿¸Æ[¿Þ°ü»óµ¿¸Æ]
  • Left corpus cavenosum of clitoris
    ¿ÞÀ½ÇÙÇØ¸éü
  • Left fibrous ring
    ¿Ü¼¶À¯°í¸®
  • Left lamina
    ¿Þ°ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • le body
    LE ¼Òü(¡­á³ô÷)
  • le cell
    LE ¼¼Æ÷(¡­á¬øà)
  • lead acetate<³ª> plumbi acetas
    ÃÊ»ê(̧Ë×)³³.
  • lead anemia
    ¿¬ºóÇ÷(æçÞ¸úì).
  • lead borosilicate
    ºØ±Ô»ê(ÝÝЩ߫)³³.
  • lead chamber
    ¿¬½Ç(ËçËà).
  • lead chromate
    Å©·Ò»ê³³<¿¬>.
  • lead colic
    ¿¬»êÅë(æçߨ÷Ô), ¿¬¼±Åë.
  • lead dichloride
    ÀÌ¿°È­(ËöËçÌ´)³³.
  • lead encephalopathy
    ¿¬³úÁõ(æçÒàñø).
  • lead glass
    ³³À¯¸®
  • lead gout
    ³³µ¶¼º<¿¬µ¶¼º> Åëdz(¡­Ô¸àõ<æçÔ¸àõ>÷Ôù¦).
  • lead iodide<³ª> plumbi iodidum
    ¿ä¿ÀµåÈ­(¡­ûù)³³.
  • lead line
    ¿¬¼±.
  • lead nephritis
    ¿¬½Å¿°(æçãìæú).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Left
    ¿Þ(ÂÊ)
    [¿¾ ¿ë¾î] ÁÂ
  • Left atrial veins
    ¿Þ½É¹æÁ¤¸Æ
    [¿¾ ¿ë¾î] Á½ɹæÁ¤¸Æ
  • Left atrioventricular orifice
    ¿Þ¹æ½Ç±¸¸Û
    [¿¾ ¿ë¾î] Á¹æ½Ç±¸
  • Left atrioventricular valve [Mitral valve]
    ¿Þ¹æ½ÇÆÇ¸· [½Â¸ðÆÇ¸·]
    [¿¾ ¿ë¾î] Á¹æ½ÇÆÇ(½Â¸ðÆÇ)
  • Left atrium
    ¿Þ½É¹æ
    [¿¾ ¿ë¾î] Á½ɹæ
  • Left auricle
    ¿Þ½É¹æ±Í
    [¿¾ ¿ë¾î] Á½ÉÀÌ
  • Left bile duct of caudate lobe
    ¿Þ²¿¸®¿±¾µ°³°ü
    [¿¾ ¿ë¾î] Á¹̻󿱴ã°ü
  • Left brachiocephalic vein
    ¿ÞÆÈ¸Ó¸®Á¤¸Æ
    [¿¾ ¿ë¾î] Á¿ϵÎÁ¤¸Æ
  • Left branch
    ¿Þ°¡Áö
    [¿¾ ¿ë¾î] ÁÂÁö
  • Left bronchomediastinal trunk
    ¿Þ±â°üÁö¼¼·ÎÄ­¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] Á±â°üÁöÁ¾°ÝÀÓÆÄº»°£
  • Left bundle branch
    ¿Þ°¥·¡
    [¿¾ ¿ë¾î] Á°¢Áö
  • Left colic artery
    ¿ÞÁÖ¸§Ã¢ÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] Á°áÀ嵿¸Æ
  • Left colic flexure
    ¿Þ(ÁÖ¸§)âÀÚ±ÁÀÌ
    [¿¾ ¿ë¾î] Á°áÀå°î
  • Left colic lymph nodes
    ¿ÞÁÖ¸§Ã¢ÀÚ¸²ÇÁÀý
    [¿¾ ¿ë¾î] Á°áÀåÀÓÆÄÀý
  • Left colic vein
    ¿ÞÁÖ¸§Ã¢ÀÚÁ¤¸Æ
    [¿¾ ¿ë¾î] Á°áÀåÁ¤¸Æ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • Le Fort's o.
    ¸£Æ÷¸£»ÀÀÚ¸§¼ú, ¸£Æ÷¸£°ñÀý´Ü¼ú
    ¸£Æ÷¸£Íéï·Ó¨âú
  • lead pipe p.
    ³³°üÇö»ó
    ҢηúÞßÚ
  • lead pipe r.
    ¿¬°ü¾ç°æÁ÷, ³³°ü¾ç°æÁ÷
    æçηåÆÌãòÁ
  • leakage
    ´©Ãâ
    שõó
  • left h.
    ¿Þ¼ÕÀâÀÌ
  • Leichtenstern's s.
    ¸®ÀÌÈ÷ÅÙ½ºÅ׸¥Â¡ÈÄ
    ¸®ÀÌÈ÷ÅÙ½ºÅ׸¥ó£ý¦
  • Leigh d.
    -> subacute necrotizing encephalomyelopathy, ¶óÀ̺´
    ¶óÀÌÜ»
  • Leigh s.
    -> subacute necrotizing encephalomyelopathy, ¶óÀÌÁõÈıº
    ¶óÀÌñøý¦ÏØ
  • leiomyoma
    ÆòȰ±ÙÁ¾
    øÁüÁÐÉðþ
  • leiomyosarcoma
    ÆòȰ±ÙÀ°Á¾
    øÁüÁÐÉë¿ðþ
  • lemniscal d.
    ¼¶À¯¶ì±³Â÷
    àéë«¶ìÎßó©
  • lemniscus
    ¼¶À¯¶ì, À¶´ë
    àéë«¶ì, ëÖÓá
  • lenticular f.
    ·»Áî½Å°æ´Ù¹ß
  • lenticulostriate a.
    ·»ÁîÇÙ¼±Á¶Ã¼µ¿¸Æ
    ·»Áîú·àÊðÉô÷ÔÑØæ
  • lentiform n.
    ·»ÁîÇÙ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Leewenhoekiidae
    ½ÖÅÐÁøµå±â°ú
  • Leishman body
    ¸®½´¸¸Ã¼
  • Leishmania mexicana mexicana infection
    ¸ß½ÃÄÚ¸®½´¸¸Æí¸ðÃæÁõ
  • leishmaniasis
    ¸®½´¸¸Æí¸ðÃæÁõ
  • leishmaniasis Digenea
    ÀÌ»ýÈíÃæ (ì£ßæýåõù)¾Æ°­
  • Lepidoptera
    ³ªºñ (ìçãÇ)¸ñ
  • levamisole
    ·¹¹Ù¹Ì¼Ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lead
    ³³(æç)
  • leader
    ¼±µµÀÚ(à»Óôí­)
  • leader peptide
    ¼±µµ(à»Óô) ÆéŸÀ̵å
  • leader protein
    ¼±µµ´Ü¹éÁú(à»ÓôÓ±ÛÜòõ)
  • leader sequence
    ¼±µµ¼­¿­(à»ÓôßíÖª)
  • leader sequence peptide
    ¼±µµ¼­¿­(à»ÓôßíÖª) ÆéŸÀ̵å
  • leading
    ¼±µµ(à»Óô)
  • leading reactant
    ¼±µµ¹ÝÀÀÁ¦(à»ÓôÚãëëð¥)
  • leading strand
    ¼±µµ(à»Óô)°¡´Ú
  • leading substrate
    ¼±µµ±âÁú(à»ÓôѨòõ)
  • leaflet
    ¼Ò¿±(á³ç¨)
  • leak current
    ´©ÃâÀü·ù(שõóï³×µ)
  • leakage
    ´©Ãâ(שõó)
  • leaky gene
    ´©ÃâÀ¯ÀüÀÚ(שõóë¶îîí­)
  • leaky mutant
    ´©Ã⺯ÀÌü(שõóܨì¶ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lead
    ³³, ¿¬, À¯µµ, ºÐ±Ø
  • lead encephalopathy
    ¿¬³úÁõ
  • lead glass
    ³³À¯¸®
  • leafless tree appearance
    ÀÙ¾ø´Â ³ª¹«¸ð¾ç
  • leak
    ´©Ãâ
  • leakage
    ´©Ãâ
  • leakage radiation
    ´©Ãâ¹æ»ç¼±
  • leather bottle appearance
    °¡Á×ÁָӴϸð¾ç
  • leather bottle stomach
    °¡Á×ÁÖ¸Ó´ÏÀ§
  • left anterior descending branch
    ÁÂÀüÇÏÇàÁö
  • left anterior oblique
    ÁÂÀü»çÀ§
  • left atrium
    Á½ɹæ
  • left auricle
    Á½ɹæ
  • left colic artery
    Á°áÀ嵿¸Æ
  • left crus of diaphragm
    Ⱦ°Ý¸·Á°¢
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • LE cell
    LE ¼¼Æ÷, È«¹Ý¼º ³¶Ã¢ ¼¼Æ÷
    µÕ±Û°í, ±ÕÁú·Î º¸ÀÌ´Â ºÀÀÔü¸¦ ޽ÄÇÑ ¼º¼÷ È£Áß±¸¼º ´ÙÇÙ ¹éÇ÷±¸. ±× ºÀÀÔü ÀÚü´Â ´Ù¸¥ È£Áß±¸¿¡¼­ À¯·¡µÈ °ÍÀÌ´Ù. È«¹Ý¼º ·çǪ½º¿¡ ƯÀ¯ÇÑ °ÍÀÌÁö¸¸ °áÇÕ Á¶Á÷ÀÇ À¯»çÇÑ Áúȯ¿¡¼­µµ °üÂûµÈ´Ù.
  • leaching
    ¿©°ú
  • lead acetate
    ÃÊ»ê ³³
  • lead anemia
    ¿¬ ºóÇ÷
    ³³¿¡ ÀÇÇÏ¿© ¹ß»ýÇÏ´Â ºóÇ÷.
  • lead borosilicate
    ºØ±Ô»ê ³³
  • lead chromate
    Å©·Ò»ê ³³
  • lead dichloride
    ÀÌ¿°È­ ³³
  • lead equivalent
    ¿¬ ´ç·®
    ¹æ»ç¼± Â÷Æó¿¡ À־ ¾î¶² ¹°ÁúÀÇ Â÷Æó È¿°ú¸¦ ±×¿Í ºñ½ÁÇÑ È¿°ú¸¦ ³ªÅ¸³»´Â ³³ÀÇ µÎ²²·Î Ç¥ÇöÇÑ °Í.
  • lead glass
    ³³ À¯¸®
    X¼± ÃÔ¿µ ½Ã 1Â÷¼±À̳ª 2Â÷¼±À¸·ÎºÎÅÍ º¸È£¹Þ±â À§ÇÏ¿© ¹æ¾î¸· ¶Ç´Â ¹æ¾îº®ÀÇ Ã¢¹®¿¡ ÀåÄ¡ÇÏ´Â À¯¸®·Î, ±× ¾È¿¡ ³³ÀÌ µé¾î ÀÖ´Â °Í.
  • lead gray
    ³³ ȸ»ö
  • lead line
    ¿¬¼±
    ³³ÀÌ ´Ù¸¥ ±Ý¼Ó ȤÀº °°Àº ³²°ú ÁßÇÕµÇ¾î »ý±ä ¼±.
  • lead neuritis
    ¿¬ ½Å°æ¿°
  • lead nitrate
    Áú»ê ³³
  • lead oleate ointment
    ´Ü¿¬ ¿¬°í
  • lead orthoplumbate
    ¿À¸£Åä³³»ê ³³
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
LE <abbreviation> Left eye; lupus erythematosus.
(05 Mar 2000)
Le antigens <haematology> A pair of blood group activities associated with the A, B, H substances. Lewis Lea is a separate gene, whereas Leb arises from the combined activity of the enzymes specified by Le(a) and H genes.
(18 Nov 1997)
Le Bel, Joseph Achille <person> French chemist, 1847-1930.
See: Le Bel-van't Hoff rule.
(05 Mar 2000)
Le Bel-van't Hoff rule The number of stereoisomers of an organic compound is 2n where n represents the number of asymmetric carbon atoms (unless there is an internal plane of symmetry). A corollary of their simultaneously announced conclusions, in 1874, that the most probable orientation of the bonds of a carbon atom linked to four groups or atoms is toward the apexes of a tetrahedron, and that this accounted for all then-known phenomena of molecular asymmetry (which involved a carbon atom bearing four different atoms or groups).
See: stereoisomerism.
(05 Mar 2000)
LE body <pathology> A globular mass of nuclear material that stains with haematoxylin, associated with lesions of systemic lupus erythematosus.
(18 Nov 1997)
LE cell <pathology> Phagocyte that has ingested nuclear material of another cell: characteristic of systemic lupus erythematosus.
(18 Nov 1997)
le cell test <investigation> A test for lupus that measures the presence of autoantibodies against nuclear proteins in the blood. Performed on a normal venipuncture specimen, this test is positive in 70 to 80% of patients with lupus. Some patients with rheumatoid arthritis, scleroderma and drug-induced lupus may also have a positive test result.
(27 Sep 1997)
Le Chatelier's law If external factors such as temperature and pressure disturb a system in equilibrium, adjustment occurs in such a way that the effect of the disturbing factors is reduced to a minimum.
Synonym: Le Chatelier's principle.
(05 Mar 2000)
Le Chatelier's principle If external factors such as temperature and pressure disturb a system in equilibrium, adjustment occurs in such a way that the effect of the disturbing factors is reduced to a minimum.
Synonym: Le Chatelier's principle.
(05 Mar 2000)
Le Chatelier, Henri <person> French physical chemist, 1850-1936.
See: Le Chatelier's law, Le Chatelier's principle.
(05 Mar 2000)
LE factors Antinuclear immunoglobulins in plasma of persons with disseminated lupus erythematosus, associated with positive LE tests.
(05 Mar 2000)
Le Fort Leon C., French surgeon and gynecologist, 1829-1893.
See: Le Fort I fracture, Le Fort II fracture, Le Fort III fracture, Le Fort sound, Le Fort's amputation.
(05 Mar 2000)
Le Fort I fracture A fracture of the facial bones in which there is a horizontal fracture at the base of the maxillae above the apices of the teeth.
Synonym: horizontal fracture, Le Fort I fracture.
(05 Mar 2000)
Le Fort II fracture A fracture of the midfacial skeleton with the principal fracture lines meeting at an apex at or near the superior aspect of the nasal bones.
Synonym: Le Fort II fracture.
(05 Mar 2000)
Le Fort III craniofacial dysjunction A complex fracture in which the facial bones are separated from the cranial bones.
Synonym: Le Fort III craniofacial dysjunction, Le Fort III fracture, transverse facial fracture.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 1
  • Lead - »õâ A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.19, symbol Pb. (Dorland, 28th)
    Synonyms :
  • Lead Poisoning - »õâ
    Synonyms : Poisoning, Lead, Lead Poisonings, Poisonings, Lead
  • Lead Poisoning, Nervous System - »õâ Injury to the nervous system secondary to exposure to lead compounds. Two distinct clinical patterns occur in children (LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD) and adults (LEAD POISONING, NERVOUS SYSTEM, ADULT). In children, lead poisoning typically produces an encephalopathy. In adults, exposure to toxic levels of lead is associated with a peripheral neuropathy.
    Synonyms : Lead Poisoning, Neurologic, Lead Neurotoxicity Syndrome, Lead Neurotoxicity Syndromes, Nervous System Plumbism, Neurologic Lead Poisoning, Neurologic Plumbism, Neurotoxicity Syndromes, Lead, Syndrome, Lead Neurotoxicity, Syndromes, Lead Neurotoxicity
  • Lead Poisoning, Nervous System, Adult - »õâ Neurologic conditions in adults associated with acute or chronic exposure to lead or any of its salts. The most common lead related neurologic syndrome in adults consists of a polyneuropathy involving motor fibers. This tends to affect distal nerves and may present as wrist drop due to RADIAL NEUROPATHY. Additional features of chronic lead exposure include ANEMIA; CONSTIPATION; colicky abdominal pain; a bluish lead line of the gums; interstitial nephritis (NEPHRITIS, INTERSTITIAL); and saturnine gout. An encephalopathy may rarely occur. (From Adams et al., Principles of Neurology, 6th ed, p1212)
    Synonyms : Lead Polyneuropathy, Lead-Induced Polyneuropathy, Polyneuropathy, Lead-Induced, Adult Neurologic Saturnism, Lead Induced Polyneuropathy, Lead-Induced Polyneuropathies, Polyneuropathies, Lead-Induced, Polyneuropathy, Lead, Polyneuropathy, Lead Induced
  • Lead Poisoning, Nervous System, Childhood - »õâ Neurologic disorders occurring in children following lead exposure. The most frequent manifestation of childhood lead toxicity is an encephalopathy associated with chronic ingestion of lead that usually presents between the ages of 1 and 3 years. Clinical manifestations include behavioral changes followed by lethargy; CONVULSIONS; HALLUCINATIONS; DELIRIUM; ATAXIA; and vomiting. Elevated intracranial pressure (HYPERTENSION, INTRACRANIAL) and CEREBRAL EDEMA may occur. (From Adams et al., Principles of Neurology, 6th ed, p1210-2)
    Synonyms : Saturine Encephalopathy, Childhood, Childhood Lead Encephalopathy, Childhood Neurologic Saturnism, Childhood Saturine Encephalopathy, Encephalopathy, Childhood Lead, Encephalopathy, Childhood Saturine, Lead Induced Nervous System Disease, Childhood
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
·ù¸Þźİ¼¿ - »õâ
Çѱ¹½´³ÚÁ¦¾à
A07150481 Acemetacin
Àü¹®ÀǾàǰ | ±Þ¿©
·¹º¸¸á½ºÁÖ500mg - »õâ
¸íÀÎÁ¦¾à
A09201921 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
·¹º¸¸á½ºÁÖ»ç¾×5g - »õâ
¸íÀÎÁ¦¾à
A09201961 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
·¹Æ÷Æ¿Á¤ - »õâ
½ì¶óÆ®ÆÊÄÚ¸®¾Æ
A23402331 Biphenyl Dimethyl Dicarboxylate
Àü¹®ÀǾàǰ | ±Þ¿©
·¹ºñ¼¿Á¤ - »õâ
´ë¿ì¾àǰ°ø¾÷
A05403331 Biphenyl Dimethyl Dicarboxylate
Àü¹®ÀǾàǰ | ±Þ¿©
·ºÅäÆÊÁ¤3mg - »õâ
Çѱ¹·Î½´
G11400031 Bromazepam
Àü¹®ÀǾàǰ | »èÁ¦
·»µ¹¹ÎÁ¤0.25mg - »õâ
Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ
G15000011 Brotizolam
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
´ÙÀ̺¸³Ø½º¾× - »õâ
Leo
E01340071 Calcipotriol
Àü¹®ÀǾàǰ | ±Þ¿©
´ÙÀ̺¸³Ø½º¿¬°í - »õâ
Leo
E01340041 Calcipotriol
Àü¹®ÀǾàǰ | ±Þ¿©
º¹ÇÕ·¹°¡·Ðݼ¿ - »õâ
ºÎ±¤¾àǰ
A13101241 Calcium pantothenate, Carduus Marianus extract, Cyanocobalamin, Nicotinamide, Pyridoxine HCl, Riboflavin, Thiamine HCl
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 7 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
leach cause (a liquid) to leach or percolate permeate or penetrate gradually; "the fertilizer leached into the ground" the process of leaching remove substances from by a percolating liquid; "leach the soil"
Ãâó: wordnet.princeton.edu/perl/webwn
lesion any visible abnormal structural change in a bodily part wound: any break in the skin or an organ caused by violence or surgical incision
Ãâó: wordnet.princeton.edu/perl/webwn
lesser omentum a part of the peritoneum attached to the stomach and liver and supporting the hepatic vessels
Ãâó: wordnet.princeton.edu/perl/webwn
lesser peritoneal cavity bursa omentalis: an isolated part of the peritoneal cavity that is dorsal to the stomach
Ãâó: wordnet.princeton.edu/perl/webwn
LET make it possible through a specific action or lack of action for something to happen; "This permits the water to rush in"; "This sealed door won't allow the water come into the basement"; "This will permit the rain to run off" actively cause something to happen; "I let it be known that I was not interested" permit: consent to, give permission; "She permitted her son to visit her estranged husband"; "I won't let the police search her basement"; "I cannot allow you to see your exam" get: cause to move; cause to be in a certain position or condition; "He got his squad on the ball"; "This let me in for a big surprise"; "He got a girl into trouble" leave unchanged; "let it be" Lashkar-e-Taiba: the most brutal terrorist group active in Kashmir; fights against India with the goal of restoring Islamic rule of India; "Lashkar-e-Toiba has committed mass murders of civilian Hindus" lease: grant use or occupation of under a term of contract; "I am leasing my country estate to some foreigners" a serve that strikes the net before falling into the receiver's court; the ball must be served again
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lea
    Ç®¹ç
  • lea
    Ç®¹ç;ÃÊ¿ø
  • leach
    °Å¸£´Ù
  • leach
    ¿©°ú(±â);Àí¹°
  • leach
    °Å¸£´Ù;°É·¯³»´Ù(³ª¿À´Ù)
  • leachate
    °Å¸¥ ¾×ü;»ïÃâ¾×
  • leachy
    ´Ù°øÁúÀÇ(Èë µûÀ§)
  • lead
    1|À̲ø´Ù,ÁöµµÇÏ´Ù,²ø´Ù,º¸³»´Ù,¿ì¼¼ 2|³³,³¬½ËºÀ,ź¾Ë
  • lead
    ³³;³³Á¦Ç°;(¿¬ÇÊÀÇ) ½É;Ãø¿¬;ÇÔ¼® ÁöºØ;heave the ~ ¼ö½ÉÀ» Àç´Ù
  • lead
    ¼±µµ;¼Ö¼±;ÁöÈÖ;Áöħ;Á¶¾ð;¿ì¼¼;(¹°À» ²ø¾îµéÀÌ´Â) µµ·®;µµ¼±;±¤¸Æ;follow the ~ of ...ÀÇ ¿¹¿¡ µû¸£´Ù
  • lead
    ¾È³»ÇÏ´Ù;(±æÀÌ) ÅëÇÏ´Ù;¼Ö¼±ÇÏ´Ù;~ away µ¥¸®°í °¡´Ù;~ by the nose ¸ÍÁ¾½ÃŰ´Ù;~ off ½ÃÀÛÇÏ´Ù;~ on ²Ò´Ù
  • lead
    ³³À» ¾º¿ì´Ù(ä¿ö ¸Å¿ì´Ù);Àε¥¸£¸¦ ä¿ì´Ù
  • lead
    Àεµ(¾È³»)ÇÏ´Ù;°Å´À¸®´Ù;²Ò´Ù;Áö³»´Ù;(»ýȰ,ÀÏ»óÀ») º¸³»´Ù
  • lead nitrate
    Áú»ê¿°
  • lead oxide
    »êÈ­¿¬
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
LE a chronic inflammatory collagen disease affecting connective tissue (skin or joints)
LE English writer of novels of espionage (born in 1931)
LE French chemist who formulated Le Chatelier's principle (1850-1936)
LE the principle that if any change is imposed on a system that is in equilibrium then the system tends to adjust to a new equilibrium counteracting the change
LE the principle that if any change is imposed on a system that is in equilibrium then the system tends to adjust to a new equilibrium counteracting the change
LE the principle that if any change is imposed on a system that is in equilibrium then the system tends to adjust to a new equilibrium counteracting the change
LE the principle that if any change is imposed on a system that is in equilibrium then the system tends to adjust to a new equilibrium counteracting the change
LE French architect (born in Switzerland) (1887-1965)
LE French primitive painter (1844-1910)
LE Vietnamese diplomat who negotiated with Henry Kissinger to end the war in Vietnam (1911-1990)
LE United States actress (born in England) (1899-1991)
LE a port city in northern France on the English Channel at the mouth of the Seine
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á